Marketing-authorisation holder
Esseti Farmaceutici S.R.L.
8 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BREINURALSoluzione iniettabile | Citicolina | Italy | Authorised | |
| CLOPIDOGREL ESSETI 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG97,86 mg · Comprimido recubierto con película | Clopidogrel | Spain | Marketed | 2009 |
| CORTRIUMPolvere e solvente per soluzione iniettabile | Methylprednisolone | Italy | Authorised | |
| HYDROXIAPolvere e solvente per soluzione iniettabile | Glutathione | Italy | Authorised | |
| LIOTIXILPolvere e solvente per soluzione iniettabile | Ceftazidime | Italy | Authorised | |
| MONACEFPolvere per soluzione iniettabile | Cefuroxime | Italy | Authorised | |
| THIOMEDPolvere e solvente per soluzione iniettabile | Glutathione | Italy | Authorised | |
| ZHAJONSoluzione iniettabile | Clodronic acid, Lidocaine | Italy | Authorised |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 7 | 7 | 0 | CompaniesAll medicines |
| Spain | 1 | 1 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antibacterials for systemic useAnti-infectives for systemic use · ATC J01D
- All other therapeutic productsVarious · ATC V03A
- Corticosteroids for systemic useSystemic hormonal preparations · ATC H02A
- Drugs for the treatment of bone diseasesMusculo-skeletal system · ATC M05B
- PsychoanalepticsNervous system · ATC N06B
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- esseti
- esseti farmaceutici s r l
- esseti farmaceutici srl
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 8
- Countries
- 2
- Roles
- Authorisation holder, manufacturer and marketer